Published : Sep-2017
No. of Pages : 161
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Rheumatoid - Inflammatory Diseases Markers Tests Overview 10
3 Products under Development 11
3.1 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development 11
3.2 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment 12
3.3 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory 13
3.4 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path 14
3.5 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date 15
4 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products under Development by Companies 16
4.1 Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development 16
4.2 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development 18
5 Rheumatoid - Inflammatory Diseases Markers Tests Companies and Product Overview 20
5.1 Abcodia Ltd Company Overview 20
5.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Albert Ludwigs University of Freiburg Company Overview 21
5.2.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Analyticon Biotechnologies AG Company Overview 22
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 AnaMar AB Company Overview 23
5.4.1 AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Arizona State University Company Overview 24
5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 AXO Science SAS Company Overview 25
5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Bayerische Patentallianz GmbH Company Overview 26
5.7.1 Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 Beckman Coulter Inc Company Overview 27
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 BioSIMS Company Overview 36
5.9.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Boditech Med Inc Company Overview 37
5.10.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 CD Diagnostics, Inc. Company Overview 38
5.11.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.12 CDI Laboratories Inc Company Overview 39
5.12.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.13 Chronix Biomedical Inc Company Overview 40
5.13.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.14 Consejo Superior de Investigaciones Cientificas Company Overview 41
5.14.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 41
5.15 DxTerity Diagnostics Inc Company Overview 42
5.15.1 DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.16 EKF Diagnostics Holdings Plc Company Overview 43
5.16.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 43
5.17 EMD Millipore Corp Company Overview 44
5.17.1 EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Epinex Diagnostics Inc Company Overview 45
5.18.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Firalis SAS Company Overview 46
5.19.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 French National Institute of Health and Medical Research Company Overview 47
5.20.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 47
5.21 Fundacio Clinic per a la Recerca Biomedica Company Overview 48
5.21.1 Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 Genalyte, Inc. Company Overview 50
5.22.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.23 GeneNews Ltd Company Overview 51
5.23.1 GeneNews Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
5.24 Ghent University Company Overview 52
5.24.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 52
5.25 Ignyta Inc Company Overview 53
5.25.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.26 Iquity Labs Inc Company Overview 56
5.26.1 Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.27 John Hopkins University Company Overview 57
5.27.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 57
5.28 KineMed Inc Company Overview 59
5.28.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.29 LifeAssays AB Company Overview 60
5.29.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 60
5.30 Louisville Bioscience, Inc. Company Overview 61
5.30.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.31 Medica Corp Company Overview 62
5.31.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 62
5.32 Myriad Genetics Inc Company Overview 63
5.32.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.33 Proplex Technologies Llc Company Overview 64
5.33.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 64
5.34 Protagen AG Company Overview 65
5.34.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 65
5.35 Queen Mary University of London Company Overview 67
5.35.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 67
5.36 Research & Diagnostic Antibodies LLC Company Overview 68
5.36.1 Research & Diagnostic Antibodies LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.37 Selventa Inc Company Overview 69
5.37.1 Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.38 SomaLogic Inc Company Overview 70
5.38.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.39 SQI Diagnostics Inc Company Overview 71
5.39.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.40 The Binding Site Group Ltd Company Overview 72
5.40.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
5.41 Thermo Fisher Scientific Inc Company Overview 74
5.41.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.42 Toscana Biomarkers Srl Company Overview 77
5.42.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 77
5.43 University Health Network Company Overview 78
5.43.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 78
5.44 University of Aberdeen Company Overview 79
5.44.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 79
5.45 University of Manchester Company Overview 80
5.45.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 80
5.46 University of Oxford Company Overview 81
5.46.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 81
5.47 University of Rochester Company Overview 82
5.47.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 82
5.48 University of Warwick Company Overview 83
5.48.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 83
5.49 University Rovira i Virgili Company Overview 84
5.49.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 84
6 Rheumatoid - Inflammatory Diseases Markers Tests- Recent Developments 85
6.1 Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 85
6.2 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers 86
6.3 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 87
6.4 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 88
6.5 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 89
6.6 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 89
6.7 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 90
6.8 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 92
6.9 Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 93
6.10 Jun 30, 2017: GeneNews Announces Election of Directors 93
6.11 Jun 29, 2017: HYCOR Biomedical Announces Senior Level Appointments to Management Team 93
6.12 Jun 15, 2017: Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra DA at the 2017 Annual European Congress of Rheumatology 94
6.13 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 95
6.14 Jun 08, 2017: Crescendo Bioscience Announces Six Studies with Vectra DA Will Be Presented at the 2017 Annual European Congress of Rheumatology 96
6.15 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 97
6.16 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 98
6.17 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 99
6.18 May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update 100
6.19 May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results 101
6.20 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 103
6.21 May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results 104
6.22 May 01, 2017: Ignyta Announces First Quarter 2017 Company Highlights and Financial Results 106
6.23 Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 107
6.24 Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 108
6.25 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 108
6.26 Apr 24, 2017: Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs 110
6.27 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 110
6.28 Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 111
6.29 Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results 112
6.30 Mar 20, 2017: EKF Diagnostics Holdings: Final results 113
6.31 Mar 14, 2017: Ignyta Announces Full Year 2016 Company Highlights and Financial Results 113
6.32 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 115
6.33 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 116
6.34 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 117
6.35 Mar 09, 2017: Alere Provides Update on Arriva Medical 118
6.36 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 118
6.37 Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 119
6.38 Mar 01, 2017: THERADIAG: Full-year 2016 results 120
6.39 Feb 23, 2017: Ablynx Announces 2016 Full Year Results 122
6.40 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 123
6.41 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 125
6.42 Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results 127
6.43 Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results 128
6.44 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 129
6.45 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 132
6.46 Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors 132
6.47 Jan 05, 2017: Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases 133
6.48 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 133
6.49 Jan 04, 2017: Alere Provides Update on Arriva Medical 134
6.50 Dec 28, 2016: Alere Provides Update on Arriva Medical 134
6.51 Dec 27, 2016: Positive Clinical Utility Results of Crescendo's Vectra DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology 135
6.52 Dec 22, 2016: United Rheumatology Issues Clinical Practice Guidelines and Recommends the Vectra DA Test for Adults with Rheumatoid Arthritis 136
6.53 Dec 20, 2016: Singulex Opens European Office and Advances IVD System Evaluation 136
6.54 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 137
6.55 Dec 12, 2016: Ignyta appoints new board member 138
6.56 Dec 12, 2016: Ignyta Appoints Steven L. Hoerter, Chief Commercial Officer of Agios Pharmaceuticals to Board of Directors 138
6.57 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 139
6.58 Dec 07, 2016: IQuity appoints new board member 139
6.59 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 140
6.60 Nov 23, 2016: Ablynx Announces Results For The First Nine Months Of 2016 And A Year-To-Date Business Update 140
6.61 Nov 12, 2016: Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting 143
6.62 Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update 144
6.63 Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update 146
6.64 Nov 07, 2016: Ignyta Announces Third Quarter 2016 Company Highlights and Financial Results 147
6.65 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 148
6.66 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 148
6.67 Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results 149
6.68 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 150
6.69 Oct 13, 2016: THERADIAG: Very strong revenue growth at end-September 2016: +31% 152
6.70 Sep 29, 2016: Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy 153
6.71 Sep 14, 2016: THERADIAG: First-half 2016 Revenues and Results 153
6.72 Sep 14, 2016: Ignyta to Present at 2016 Silicon Valley Bank Healthcare Capital and Connections Summit 154
6.73 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 155
7 Appendix 158
7.1 Methodology 158
7.2 About GlobalData 161
7.3 Contact Us 161
7.4 Disclaimer 161
1.1 List of Tables
Table 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development 11
Table 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment 12
Table 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory 13
Table 4: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path 14
Table 5: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date 15
Table 6: Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development 16
Table 7: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development 18
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 9: Molecular Biomarker - Rheumatoid Arthritis - Product Status 20
Table 10: Molecular Biomarker - Rheumatoid Arthritis - Product Description 20
Table 11: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 21
Table 12: Diagnostic Kit - Rheumatoid Arthritis - Product Status 21
Table 13: Diagnostic Kit - Rheumatoid Arthritis - Product Description 21
Table 14: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 22
Table 15: Turbitex ASL - Product Status 22
Table 16: Turbitex ASL - Product Description 22
Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 23
Table 18: NeoSix Biomarker Assay - Product Status 23
Table 19: NeoSix Biomarker Assay - Product Description 23
Table 20: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 24
Table 21: Diagnostic Test - Rheumatoid Arthritis - Product Status 24
Table 22: Diagnostic Test - Rheumatoid Arthritis - Product Description 24
Table 23: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 25
Table 24: Multiplexed Detection - CRP - Product Status 25
Table 25: Multiplexed Detection - CRP - Product Description 25
Table 26: Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
Table 27: Prognostic Test - Rheumatoid Arthritis - Product Status 26
Table 28: Prognostic Test - Rheumatoid Arthritis - Product Description 26
Table 29: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 30: AU480 Clinical System - anti-CCP Assay - Product Status 27
Table 31: AU480 Clinical System - anti-CCP Assay - Product Description 28
Table 32: AU5810 Clinical System - anti-CCP Assay - Product Status 28
Table 33: AU5810 Clinical System - anti-CCP Assay - Product Description 28
Table 34: AU5820 Clinical System - anti-CCP Assay - Product Status 29
Table 35: AU5820 Clinical System - anti-CCP Assay - Product Description 29
Table 36: AU5830 Clinical System - anti-CCP Assay - Product Status 29
Table 37: AU5830 Clinical System - anti-CCP Assay - Product Description 30
Table 38: AU5840 Clinical System - anti-CCP Assay - Product Status 30
Table 39: AU5840 Clinical System - anti-CCP Assay - Product Description 30
Table 40: AU680 Clinical System - anti-CCP Assay - Product Status 31
Table 41: AU680 Clinical System - anti-CCP Assay - Product Description 31
Table 42: UniCel DxC 600 - anti-CCP Assay - Product Status 31
Table 43: UniCel DxC 600 - anti-CCP Assay - Product Description 32
Table 44: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Status 32
Table 45: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Description 32
Table 46: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Status 33
Table 47: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Description 33
Table 48: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Status 33
Table 49: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Description 34
Table 50: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Status 34
Table 51: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Description 34
Table 52: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Status 35
Table 53: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Description 35
Table 54: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 36
Table 55: DigiPLEX Analyzer - Rheumatology Assay - Product Status 36
Table 56: DigiPLEX Analyzer - Rheumatology Assay - Product Description 36
Table 57: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 58: AFIAS-6 RF IgM Assay - Product Status 37
Table 59: AFIAS-6 RF IgM Assay - Product Description 37
Table 60: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 61: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Status 38
Table 62: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Description 38
Table 63: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 64: Diagnostic Test - Rheumatoid Arthritis - Product Status 39
Table 65: Diagnostic Test - Rheumatoid Arthritis - Product Description 39
Table 66: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 67: Companion Diagnostic Test - Rheumatoid Arthritis - Product Status 40
Table 68: Companion Diagnostic Test - Rheumatoid Arthritis - Product Description 40
Table 69: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 41
Table 70: Diagnostic Assay - Rheumatoid Arthritis - Product Status 41
Table 71: Diagnostic Assay - Rheumatoid Arthritis - Product Description 41
Table 72: DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 73: RADx - Product Status 42
Table 74: RADx - Product Description 42
Table 75: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 76: Quo-Lab - C-Reactive Protein - Product Status 43
Table 77: Quo-Lab - C-Reactive Protein - Product Description 43
Table 78: EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 44
Table 79: Erenna System - Rheumatoid Arthritis - Product Status 44
Table 80: Erenna System - Rheumatoid Arthritis - Product Description 44
Table 81: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 82: Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test - Product Status 45
Table 83: Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test - Product Description 45
Table 84: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 46
Table 85: Biomarker Test - Rheumatoid Arthritis - Product Status 46
Table 86: Biomarker Test - Rheumatoid Arthritis - Product Description 46
Table 87: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 47
Table 88: GPI Biomarker Assay - Arthritis - Product Status 47
Table 89: GPI Biomarker Assay - Arthritis - Product Description 47
Table 90: Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview 48
Table 91: Diagnostic Assay - Rheumatoid Arthritis - Product Status 48
Table 92: Diagnostic Assay - Rheumatoid Arthritis - Product Description 48
Table 93: Early Diagnostic Assay - Rheumatoid Arthritis - Product Status 49
Table 94: Early Diagnostic Assay - Rheumatoid Arthritis - Product Description 49
Table 95: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 96: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Status 50
Table 97: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Description 50
Table 98: GeneNews Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 99: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status 51
Table 100: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description 51
Table 101: Ghent University Pipeline Products & Ongoing Clinical Trials Overview 52
Table 102: Biomarker Test - Spondyloarthropathy - Product Status 52
Table 103: Biomarker Test - Spondyloarthropathy - Product Description 52
Table 104: Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 105: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Status 53
Table 106: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Description 53
Table 107: TrailblazeDx Test - Rheumatoid Arthritis - Product Status 54
Table 108: TrailblazeDx Test - Rheumatoid Arthritis - Product Description 54
Table 109: TrailblazeTx Test - Rheumatoid Arthritis - Product Status 54
Table 110: TrailblazeTx Test - Rheumatoid Arthritis - Product Description 55
Table 111: Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 112: IsolateRheum - Product Status 56
Table 113: IsolateRheum - Product Description 56
Table 114: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 57
Table 115: Anti-PAD3 Based Diagnostic Assay - Rheumatoid Arthritis - Product Status 57
Table 116: Anti-PAD3 Based Diagnostic Assay - Rheumatoid Arthritis - Product Description 57
Table 117: Biomarker Assay - Rheumatoid Arthritis - Product Status 58
Table 118: Biomarker Assay - Rheumatoid Arthritis - Product Description 58
Table 119: KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 120: Diagnostic Assay - Collagen Synthesis - Product Status 59
Table 121: Diagnostic Assay - Collagen Synthesis - Product Description 59
Table 122: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 60
Table 123: LifeAssays hsCRP - Product Status 60
Table 124: LifeAssays hsCRP - Product Description 60
Table 125: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 126: Rheumatoid Arthritis pT Autoimmune Test - Product Status 61
Table 127: Rheumatoid Arthritis pT Autoimmune Test - Product Description 61
Table 128: Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 62
Table 129: EasyRA Analyzer - RF Assay - Product Status 62
Table 130: EasyRA Analyzer - RF Assay - Product Description 62
Table 131: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 132: myPath Psoriatic Arthritis - Product Status 63
Table 133: myPath Psoriatic Arthritis - Product Description 63
Table 134: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 135: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status 64
Table 136: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description 64
Table 137: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 65
Table 138: Multilisa RA - Product Status 65
Table 139: Multilisa RA - Product Description 65
Table 140: NavigAID Rheumatoid Arthritis - Product Status 66
Table 141: NavigAID Rheumatoid Arthritis - Product Description 66
Table 142: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 67
Table 143: Biomarker Assay - Rheumatoid Arthritis - Product Status 67
Table 144: Biomarker Assay - Rheumatoid Arthritis - Product Description 67
Table 145: Research & Diagnostic Antibodies LLC Pipeline Products & Ongoing Clinical Trials Overview 68
Table 146: Diagnostic Test - Rheumatoid Arthritis - Product Status 68
Table 147: Diagnostic Test - Rheumatoid Arthritis - Product Description 68
Table 148: Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 149: Clarify - Rheumatoid Arthritis - Product Status 69
Table 150: Clarify - Rheumatoid Arthritis - Product Description 69
Table 151: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 152: SOMAscan Assay - Rheumatoid Arthritis - Product Status 70
Table 153: SOMAscan Assay - Rheumatoid Arthritis - Product Description 70
Table 154: SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 155: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Status 71
Table 156: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Description 71
Table 157: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
Table 158: Optilite - C-reactive Protein Test - Product Status 72
Table 159: Optilite - C-reactive Protein Test - Product Description 72
Table 160: Optilite - High Sensitive C-reactive Protein Kit - Product Status 73
Table 161: Optilite - High Sensitive C-reactive Protein Kit - Product Description 73
Table 162: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 74
Table 163: Phadia 2500 Laboratory System - RF IgM/IgA Test - Product Status 74
Table 164: Phadia 2500 Laboratory System - RF IgM/IgA Test - Product Description 75
Table 165: Phadia 5000 Laboratory System - CCP Test - Product Status 75
Table 166: Phadia 5000 Laboratory System - CCP Test - Product Description 75
Table 167: Phadia 5000 Laboratory System - RF IgM/IgA Test - Product Status 76
Table 168: Phadia 5000 Laboratory System - RF IgM/IgA Test - Product Description 76
Table 169: Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 77
Table 170: Diagnostic Assay - Rheumatoid Arthritis - Product Status 77
Table 171: Diagnostic Assay - Rheumatoid Arthritis - Product Description 77
Table 172: University Health Network Pipeline Products & Ongoing Clinical Trials Overview 78
Table 173: Biomarker Test - Rheumatoid Arthritis - Product Status 78
Table 174: Biomarker Test - Rheumatoid Arthritis - Product Description 78
Table 175: University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 79
Table 176: Diagnostic Assay - Rheumatoid Arthritis - Product Status 79
Table 177: Diagnostic Assay - Rheumatoid Arthritis - Product Description 79
Table 178: University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 80
Table 179: Molecular Pathology Test - Rheumatoid Arthritis - Product Status 80
Table 180: Molecular Pathology Test - Rheumatoid Arthritis - Product Description 80
Table 181: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 81
Table 182: Biomarker Based Assay - Rheumatoid Arthritis - Product Status 81
Table 183: Biomarker Based Assay - Rheumatoid Arthritis - Product Description 81
Table 184: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 82
Table 185: PBMC-Based Companion Diagnostic Test - Product Status 82
Table 186: PBMC-Based Companion Diagnostic Test - Product Description 82
Table 187: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 83
Table 188: Diagnostic Test - Arthritis - Product Status 83
Table 189: Diagnostic Test - Arthritis - Product Description 83
Table 190: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 84
Table 191: CD-Medics Test - RA - Product Status 84
Table 192: CD-Medics Test - RA - Product Description 84
Table 193: Glossary 160
1.2 List of Figures
Figure 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development 11
Figure 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment 12
Figure 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory 13
Figure 4: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path 14
Figure 5: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date 15
